Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11879133 Gene therapy for ocular disorders

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 24, 2018
0
Date of Patent
January 23, 2024
0
Patent Application Number
16607834
0
Patent Citations
‌
US Patent 7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use
0
‌
US Patent 7172893 Virus vectors and methods of making and administering the same
0
‌
US Patent 7201898 Methods and compounds for controlled release of recombinant parvovirus vectors
0
‌
US Patent 7229823 Methods for increasing the efficiency of recombinant AAV product
0
‌
US Patent 7282199 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
0
‌
US Patent 7439065 Helper virus-free AAV production
0
‌
US Patent 7456683 Amplitude error compensating device and quadrature skew error compensating device
0
‌
US Patent 7588772 AAV capsid library and AAV capsid proteins
0
‌
US Patent 7629322 AAV vector for gene therapy
0
‌
US Patent 7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
0
•••
Patent Inventor Names
Jean Bennett
0
Kenneth Shindler
0
Devin McDougald
0
Junwei Sun
0
Ahmara Gibbons Ross
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11879133
0
Patent Primary Examiner
‌
Arthur S Leonard
0
CPC Code
‌
A61P 27/02
0
‌
A61K 48/00
0
‌
C12N 15/86
0
‌
C12N 2710/10043
0
‌
A61K 9/0048
0

Find more entities like US Patent 11879133 Gene therapy for ocular disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.